The γ-Secretase Complex: From Discovery to Therapeutic Target

Abstract

γ-Secretase is an intricate intramembrane aspartyl protease that cleaves within the transmembrane domain of ~150 substrates and considered the 'proteasome of membrane'. This enzyme consists of four different subunits, with presenilin being the catalytic subunit. This review provides a brief overview of γ-secretase as a proteolytic enzyme, from its biochemistry and biology to its roles in disease and potential as a therapeutic target. A detailed discussion on the discovery and structure of γ-secretase is followed by a survey of its substrates, including the most studied amyloid precursor protein and Notch1 receptor, and description of substrate processing and sequence specificity. The role of γ-secretase in human biology and pathology is also detailed, with a particular focus on Alzheimer's disease (AD), in which the pathogenicity of the γ-secretase product amyloid-β peptide is still a matter of controversy. Lastly, the potential of γ-secretase inhibitors and modulators for the treatment of AD and other diseases is considered.

Article information

Article type
Review Article
Submitted
23 Jan 2026
Accepted
03 Jun 2026
First published
05 Jun 2026
This article is Open Access
Creative Commons BY license

RSC Chem. Biol., 2026, Accepted Manuscript

The γ-Secretase Complex: From Discovery to Therapeutic Target

S. R. Malvankar and M. S. Wolfe, RSC Chem. Biol., 2026, Accepted Manuscript , DOI: 10.1039/D6CB00022C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements